CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium

Detalhes bibliográficos
Autor(a) principal: Metello, Luís F.
Data de Publicação: 2013
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.22/3310
Resumo: CYCLOTech is a high-tech Project, related with an innovative method for direct production of a radioactive pharmaceutical, used in excess of 85% of 35 Million Nuclear Medicine procedures done yearly, worldwide, representing globally more than 3 Billion Euros. The CYCLOTech team has developed an innovative proprietary methodology based on the use of Cyclotron Centers, formally identified as the Clients (actually, there are around 450 of this Centers in function worldwide), to directly produce and deliver the radiopharmaceutical to the final users, at the Hospitals and other Health Institutions (estimating at around 25.000, worldwide). The investment still need to finish Research and Technological Development (RTD), Industrial, Regulatory and Intellectual Property Rights (IPR) issues and allow the introduction in the Market is 4,35 M€, with a Payback of 3 years, with an Investment Return Rate (IRR) of 81,7% and a Net Present Value (NPV) of 60.620.525€ (in 2020).
id RCAP_b127556bc4eb4bb52e325b88aed055d4
oai_identifier_str oai:recipp.ipp.pt:10400.22/3310
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling CYCLOTech - an innovative approach for the reliable production of 99mTc - technetiumCYCLOTech is a high-tech Project, related with an innovative method for direct production of a radioactive pharmaceutical, used in excess of 85% of 35 Million Nuclear Medicine procedures done yearly, worldwide, representing globally more than 3 Billion Euros. The CYCLOTech team has developed an innovative proprietary methodology based on the use of Cyclotron Centers, formally identified as the Clients (actually, there are around 450 of this Centers in function worldwide), to directly produce and deliver the radiopharmaceutical to the final users, at the Hospitals and other Health Institutions (estimating at around 25.000, worldwide). The investment still need to finish Research and Technological Development (RTD), Industrial, Regulatory and Intellectual Property Rights (IPR) issues and allow the introduction in the Market is 4,35 M€, with a Payback of 3 years, with an Investment Return Rate (IRR) of 81,7% and a Net Present Value (NPV) of 60.620.525€ (in 2020).CYCLOTech é o nome que designa um Projecto eminentemente tecnológico, relacionado com o desenvolvimento de um método inovador para produção directa de um medicamento radioactivo (99mTc- Tecnécio), usado em mais de 85% dos cerca de 35 Milhões de exames efectuados em Medicina Nuclear anualmente, representando globalmente mais de 3 mil milhões de Euros no Mercado Global. CYCLOTech representa o desenvolvimento de uma metodologia inovadora própria, baseada no uso de Centros equipados com Ciclotrões (existindo cerca de 450 Centros deste tipo pelo mundo) para produção directa do 99mTc e distribuição aos utilizadores finais, nos Departamentos de Medicina Nuclear existentes nos Hospitais (e que são cerca de 25.000 distribuídos pelo mundo). O investimento necessário para garantir as condições para finalizar a pesquisa e resolver as questões industriais, regulatórias e as inerentes à Protecção dos Direitos de Propriedade Intelectual e Industrial e à introdução no mercado é de cerca de 4,35 M€, com um Payback de 3 anos, uma Taxa Interna de Retorno (TIR) de 81,7% e um Valor Actual Líquido (VAL) de 60.620.525€ (em 2020).Instituto Politécnico do Porto. Escola Superior da Tecnologia de Saúde do PortoRepositório Científico do Instituto Politécnico do PortoMetello, Luís F.2014-01-13T14:56:57Z20132013-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.22/3310enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-03-13T12:43:04Zoai:recipp.ipp.pt:10400.22/3310Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:24:17.685622Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
title CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
spellingShingle CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
Metello, Luís F.
title_short CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
title_full CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
title_fullStr CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
title_full_unstemmed CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
title_sort CYCLOTech - an innovative approach for the reliable production of 99mTc - technetium
author Metello, Luís F.
author_facet Metello, Luís F.
author_role author
dc.contributor.none.fl_str_mv Repositório Científico do Instituto Politécnico do Porto
dc.contributor.author.fl_str_mv Metello, Luís F.
description CYCLOTech is a high-tech Project, related with an innovative method for direct production of a radioactive pharmaceutical, used in excess of 85% of 35 Million Nuclear Medicine procedures done yearly, worldwide, representing globally more than 3 Billion Euros. The CYCLOTech team has developed an innovative proprietary methodology based on the use of Cyclotron Centers, formally identified as the Clients (actually, there are around 450 of this Centers in function worldwide), to directly produce and deliver the radiopharmaceutical to the final users, at the Hospitals and other Health Institutions (estimating at around 25.000, worldwide). The investment still need to finish Research and Technological Development (RTD), Industrial, Regulatory and Intellectual Property Rights (IPR) issues and allow the introduction in the Market is 4,35 M€, with a Payback of 3 years, with an Investment Return Rate (IRR) of 81,7% and a Net Present Value (NPV) of 60.620.525€ (in 2020).
publishDate 2013
dc.date.none.fl_str_mv 2013
2013-01-01T00:00:00Z
2014-01-13T14:56:57Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.22/3310
url http://hdl.handle.net/10400.22/3310
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Instituto Politécnico do Porto. Escola Superior da Tecnologia de Saúde do Porto
publisher.none.fl_str_mv Instituto Politécnico do Porto. Escola Superior da Tecnologia de Saúde do Porto
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131337208102912

Registros relacionados